Review Articles
Vol. 12 No. 1 (2020): Mediterranean Journal of Hematology and Infectious Diseases, Volume 12, 2020
- KAWASAKI DISEASE AS THE IMMUNE-MEDIATED ECHO OF A VIRAL INFECTION
Kawasaki Disease and Viral Infections
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: May 21, 2020
Accepted: June 15, 2020
Accepted: June 15, 2020
1746
Views
916
Downloads
326
HTML
Authors
Although etiology of Kawasaki disease remains elusive, the available evidence indicates that the primum movens might be a dysregulation of immune responses to various microbes, i.e. a kind of immune-mediated response induced by a viral infection. Even if several data might suggest that Kawasaki disease is an infection-related clinical syndrome, which can develop only in children with a predisposing genetic background, our knowledge on both the infectious agents involved and the genetic characteristics of children prone to the disease remains poor.
Downloads
Download data is not yet available.
Citations
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16:178-222. PMid: 6062087
Kawasaki T, Kosaki F, Okawa S, et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6. PMid: 4153258
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. doi: 10.1542/peds.2004-2182 PMid: 15574639
Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J 2011;9:17. doi: 10.1186/1546-0096-9-17 PMid: 21774801
Amano S, Hazama F, Kubagawa H, et al. General pathology of Kawasaki disease on the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980;30:681-94. PMid: 7446109
Hamashima Y. Kawasaki disease. Heart Vessels Suppl 1985;1:271-6. doi: 10.1007/BF02072407 PMid: 3843587
Suzuki A, Miyagawa-Tomita S, Komatsu K, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 2000;101:2935-41. doi: 10.1161/01.cir.101.25.2935 PMid: 10869266
De Rosa G, Pardeo M, Rigante D. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci 2007;11:301-8. PMid: 18074939
Marchesi A, Tarissi De Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr 2018;44(1):102. doi: 10.1186/s13052-018-0536-3 PMid: 30157897
Marchesi A, Tarissi De Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Ital J Pediatr 2018;44(1):103. doi: 10.1186/s13052-018-0529-2 PMid: 30157893
Rigante D, Valentini P, Rizzo D, et al. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 2010;30:841-6. doi: 10.1007/s00296-009-1337-1 PMid: 20049445
Rigante D, Andreozzi L, Fastiggi M, et al. Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome. Int J Mol Sci 2016;17:278. doi: 10.3390/ijms17030278 PMid: 26927060
Falcini F, Ozen S, Magni-Manzoni S, et al. Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study. Clin Exp Rheumatol 2012;30:799-804. PMid: 23020938
Stabile A, Bertoni B, Ansuini V, et al. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 2006;10:53-9. PMid: 16705949
Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. J Infect 2013;67:1-10. doi: 10.1016/j.jinf.2013.04.004. PMid: 23603251
Rigante D, Tarantino G, Valentini P. Non-infectious makers of Kawasaki syndrome: tangible or elusive triggers? Immunol Res 2016;64:51-4. doi: 10.1007/s12026-015-8679-4 PMid: 26232895
Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018;6:374. doi: 10.3389/fped.2018.00374 PMid: 30619784
Burns JC, Herzog L, Fabri O, et al. Seasonality of Kawasaki disease: a global perspective. PLoS One 2013;8(9):e74529. doi: 10.1371/journal.pone.0074529 PMid: 24058585
Shimizu D, Hoshina T, Kawamura M, et al. Seasonality in clinical courses of Kawasaki disease. Arch Dis Child 2019;104:694-6. doi: 10.1136/archdischild-2018-315267 PMid: 30413486
Turnier JL, Anderson MS, Heizer HR, et al. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136:e609-14. doi: 10.1542/peds.2015-0950 PMid: 26304824
Jordan-Villegas A, Chang ML, Ramilo O, et al. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J 2010;29:770-2. doi: 10.1097/INF.0b013e3181dba70b PMid: 20354462
Benseler SM, McCrindle BW, Silverman ED, et al. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005;116:e760-6. doi: 10.1542/peds.2005-0559 PMid: 16322132
Matsuno S, Utagawa E, Sugiura A. Association of rotavirus infection with Kawasaki syndrome. J Infect Dis 1983;148:177. doi: 10.1093/infdis/148.1.177 PMid: 6309994
Johnson D, Azimi P. Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection. Pediatr Infect Dis J 1985;4:100-3. doi: 10.1097/00006454-198501000-00024 PMID: 2982131
Embil JA, McFarlane ES, Murphy DM, et al. Adenovirus type 2 isolated from a patient with fatal Kawasaki disease. Can Med Assoc J 1985;132:1400. PMid: 4005729
Jaggi P, Kajon AE, Mejias A, et al. Human adenovirus infection in Kawasaki disease: a confounding bystander? Clin Infect Dis 2013;56:58-64. doi: 10.1093/cid/cis807 PMid: 23011145
Song E, Kajon AE, Wang H, et al. Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection. J Pediatr 2016;170:325-30. doi: 10.1016/j.jpeds.2015.11.021 PMid: 26707621
Okano M, Luka J, Thiele GM, et al. Human herpesvirus 6 infection and Kawasaki disease. J Clin Microbiol 1989;27:2379-80. PMid: 2555393
Hagiwara K, Komura H, Kishi F, Kaji T, Yoshida T. Isolation of human herpesvirus-6 from an infant with Kawasaki disease. Eur J Pediatr 1992;151:867-8. PMid: 1334835
Holm JM, Hansen LK, Oxhøj H. Kawasaki disease associated with parvovirus B19 infection. Eur J Pediatr 1995;154:633-4. doi: 10.1007/BF02079066 PMid: 7588963
Usta Guc B, Cengiz N, Yildirim SV, et al. Cytomegalovirus infection in a patient with atypical Kawasaki disease. Rheumatol Int 2008;28:387-9. doi: 10.1007/s00296-007-0440-4 PMid: 17717671
Kanegane H, Tsuji T, Seki H, et al. Kawasaki disease with a concomitant primary Epstein-Barr virus infection. Acta Paediatr Jpn 1994;36 713-6. doi: 10.1111/j.1442-200x.1994.tb03277.x PMid: 7871990
Kikuta H, Matsumoto S, Yanase Y, et al. Recurrence of Kawasaki disease and Epstein-Barr virus infection. J Infect Dis 1990;162:1215. doi 10.1093/infdis/162.5.1215 PMid: 2172398
Kuijpers TW, Herweijer TJ, Scholvinck L, et al. Kawasaki disease associated with measles virus infection in a monozygotic twin. Pediatr Infect Dis J 2000;19:350-3. doi: 10.1097/00006454-200004000-00018 PMid: 10783028
Shingadia D, Bose A, Booy R. Could a herpesvirus be the cause of Kawasaki disease? Lancet Infect Dis 2002;2:310-3. doi: 10.1016/s1473-3099(02)00265-7 PMid: 12062997
Lee DH, Huang HP. Kawasaki disease associated with chickenpox: report of two sibling cases. Acta Paediatr Taiwan 2004;45:94-6. PMid: 15335119
Joshi AV, Jones KD, Buckley AM, et al. Kawasaki disease coincident with influenza A H1N1/09 infection. Pediatr Int 2011;53:e1-2. doi: 10.1111/j.1442-200X.2010.03280.x PMid: 21342333
Huang X, Huang P, Zhang L, et al. Influenza infection and Kawasaki disease. Rev Soc Bras Med Trop 2015;48:243-8. doi: 10.1590/0037-8682-0091-2015 PMid: 26108000
Rigante D, Cantarini L, Piastra M, et al. Kawasaki syndrome and concurrent Coxsackie-virus B3 infection. Rheumatol Int 2012;32:4037-40. doi: 10.1007/s00296-010-1613-0 PMid: 21052673
Catalano-Pons C, Giraud C, Rozenberg F, et al. Detection of human bocavirus in children with Kawasaki disease. Clin Microbiol Infect 2007;13:1220-2. doi: 10.1111/j.1469-0691.2007.01827.x PMid: 17850342
Santos RA, Nogueira CS, Granja S, et al. Kawasaki disease and human bocavirus-potential association? J Microbiol Immunol Infect 2011;44:235-7. doi: 10.1016/j.jmii.2011.01.016 PMid: 21524620
Bajolle F, Meritet JF, Rozenberg F, et al. Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study". Pathol Biol (Paris) 2014;62:365-8. doi: 10.1016/j.patbio.2014.06.002 PMid: 25193448
Thissen JB, Isshiki M, Jaing C, et al. A novel variant of torque teno virus 7 identified in patients with Kawasaki disease. PLoS One 2018;13(12):e0209683. doi: 10.1371/journal.pone.0209683 PMid: 30592753
Maggio MC, Fabiano C, Corsello G. Kawasaki disease triggered by EBV virus in a child with familial Mediterranean fever. Ital J Pediatr 2019;45:129. doi: 10.1186/s13052-019-0717-8 PMid: 31627741
Maggio MC, Cimaz R, Alaimo A, et al. Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings. J Med Case Rep 2019;13:104. doi: 10.1186/s13256-019-2028-5 PMid: 31014402
Wang J, Sun F, Deng HL, et al. Influenza A (H1N1) pdm09 virus infection in a patient with incomplete Kawasaki disease: A case report. Medicine (Baltimore) 2019;98(15):e15009. doi: 10.1097/MD.0000000000015009 PMid: 30985646
Chang LY, Lu CY, Shao PL, et al. Viral infections associated with Kawasaki disease. J Formos Med Assoc 2014;113:148-54. doi: 10.1016/j.jfma.2013.12.008 PMid: 24495555
Esper F, Shapiro ED, Weibel C, et al. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis 2005;191:499-502. doi: 10.1086/428291 PMid: 15655771
Dominguez SR, Anderson MS, Glodé MP, et al. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis 2006;194:1697-01. doi: 10.1086/509509 PMid: 17109341
Shirato K, Imada Y, Kawase M, et al. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virol 2014;86:2146-53. doi: 10.1002/jmv.23950 PMid: 24760654
Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020;10:537-40. doi: 10.1542/hpeds.2020-0123 PMid: 32265235
Rivera-Figueroa EI, Santos R, Simpson S, et al. Incomplete Kawasaki Disease in a child with Covid-19. Indian Pediatr 2020 May 9:S097475591600179. PMid: 32393680
Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020;395(10239): 1771-8. doi: 10.1016/S0140-6736(20)31103-X PMid: 32410760
Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020 Jun 29. doi: 10.1056/NEJMoa2021756 PMid: 32598830
Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One 2008;3:e1582. doi: 10.1371/journal.pone.0001582 PMid: 18270572
Rowley AH, Baker SC, Shulman ST, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis 2011;203:1021-30. doi: 10.1093/infdis/jiq136 PMid: 21402552
L'Huillier AG, Brito F, Wagner N, et al. Identification of viral signatures using high-throughput sequencing on blood of patients with Kawasaki disease. Front Pediatr 2019;7:524. doi: 10.3389/fped.2019.00524 PMid: 31921732
Esposito S, Polinori I, Rigante D. The gut microbiota-host partnership as a potential driver of Kawasaki syndrome. Front Pediatr 2019;7:124. doi: 10.3389/fped.2019.00124 PMid: 31024869
Marrani E, Burns JC, Cimaz R. How should we classify Kawasaki disease? Front Immunol 2018;9:2974. doi: 10.3389/fimmu.2018.02974 PMid: 30619331
Rigante D. A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner. Expert Rev Clin Immunol 2017;13:571-97. doi: 10.1080/1744666X.2017.1280396 PMid: 28064547
Rigante D. The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children. Mediterr J Hematol Infect Dis 2018;10(1):e2018067. doi: 10.4084/MJHID.2018.067 PMid: 30416699
Rigante D, Frediani B, Galeazzi M, et al. From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int 2013;2013:485103. doi: 10.1155/2013/485103 PMid: 23971037
Ethics Approval
-Supporting Agencies
-How to Cite
“- KAWASAKI DISEASE AS THE IMMUNE-MEDIATED ECHO OF A VIRAL INFECTION: Kawasaki Disease and Viral Infections” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020039. doi:10.4084/mjhid.2020.039.
